Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data

BACKGROUND: The X‐ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H(1)‐antihistamines. METHODS: In X‐ACT, a phase III, double‐blind, placebo‐controlled study, CSU patien...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Allergy
Prif Awduron: Staubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Maurer, M., Weller, K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
ORIGINAL ARTICLES
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836932/
https://ncbi.nlm.nih.gov/pubmed/29058822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13339
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg